INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,624,516 | -16.5% | 146,372 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $9,126,882 | +95.7% | 144,139 | +67.4% | 0.00% | +50.0% |
| Q1 2023 | $4,663,777 | +9.3% | 86,127 | +6.8% | 0.00% | 0.0% |
| Q4 2022 | $4,265,828 | +13.2% | 80,609 | -0.5% | 0.00% | +100.0% |
| Q3 2022 | $3,770,000 | -21.1% | 81,029 | -3.2% | 0.00% | -50.0% |
| Q2 2022 | $4,779,000 | +0.6% | 83,731 | +7.9% | 0.00% | +100.0% |
| Q1 2022 | $4,750,000 | +37.0% | 77,627 | +17.2% | 0.00% | 0.0% |
| Q4 2021 | $3,466,000 | +54.2% | 66,224 | +9.8% | 0.00% | 0.0% |
| Q3 2021 | $2,248,000 | +17.7% | 60,295 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $1,910,000 | +20.3% | 46,803 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $1,588,000 | +23.7% | 46,774 | +15.9% | 0.00% | 0.0% |
| Q4 2020 | $1,284,000 | +23.3% | 40,369 | -0.5% | 0.00% | – |
| Q3 2020 | $1,041,000 | -3.2% | 40,555 | -3.2% | 0.00% | -100.0% |
| Q2 2020 | $1,075,000 | +166.1% | 41,877 | +59.3% | 0.00% | – |
| Q1 2020 | $404,000 | -44.3% | 26,285 | +24.5% | 0.00% | – |
| Q4 2019 | $725,000 | +433.1% | 21,107 | +15.9% | 0.00% | – |
| Q3 2019 | $136,000 | -34.9% | 18,215 | +13.5% | 0.00% | – |
| Q2 2019 | $209,000 | +6.6% | 16,044 | 0.0% | 0.00% | – |
| Q1 2019 | $196,000 | +7.1% | 16,044 | 0.0% | 0.00% | – |
| Q4 2018 | $183,000 | -42.6% | 16,044 | +9.4% | 0.00% | – |
| Q3 2018 | $319,000 | +23.2% | 14,670 | 0.0% | 0.00% | – |
| Q2 2018 | $259,000 | -20.8% | 14,670 | -5.5% | 0.00% | – |
| Q1 2018 | $327,000 | +20.7% | 15,532 | -16.4% | 0.00% | – |
| Q4 2017 | $271,000 | +1.9% | 18,590 | +9.7% | 0.00% | – |
| Q3 2017 | $266,000 | +160.8% | 16,942 | +105.7% | 0.00% | – |
| Q2 2017 | $102,000 | -23.9% | 8,235 | 0.0% | 0.00% | – |
| Q1 2017 | $134,000 | +5.5% | 8,235 | -1.4% | 0.00% | – |
| Q4 2016 | $127,000 | +98.4% | 8,350 | +89.9% | 0.00% | – |
| Q3 2016 | $64,000 | -67.7% | 4,398 | -16.7% | 0.00% | – |
| Q2 2016 | $198,000 | +76.8% | 5,282 | +29.3% | 0.00% | – |
| Q1 2016 | $112,000 | -38.1% | 4,085 | +22.2% | 0.00% | – |
| Q4 2015 | $181,000 | +42.5% | 3,343 | 0.0% | 0.00% | – |
| Q3 2015 | $127,000 | +23.3% | 3,343 | 0.0% | 0.00% | – |
| Q2 2015 | $103,000 | +25.6% | 3,343 | 0.0% | 0.00% | – |
| Q1 2015 | $82,000 | +36.7% | 3,343 | 0.0% | 0.00% | – |
| Q4 2014 | $60,000 | +25.0% | 3,343 | 0.0% | 0.00% | – |
| Q3 2014 | $48,000 | – | 3,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |